- Home
- TXMD vs AMST Comparison
TXMD vs AMST Comparison
Compare TXMD & AMST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TXMD
- AMST
- Stock Information
- Founded
- TXMD 2008
- AMST 2017
- Country
- TXMD United States
- AMST United States
- Employees
- TXMD N/A
- AMST N/A
- Industry
- TXMD Biotechnology: Pharmaceutical Preparations
- AMST Computer Software: Prepackaged Software
- Sector
- TXMD Health Care
- AMST Technology
- Exchange
- TXMD Nasdaq
- AMST Nasdaq
- Market Cap
- TXMD 12.7M
- AMST 13.3M
- IPO Year
- TXMD N/A
- AMST 2020
- Fundamental
- Price
- TXMD $1.07
- AMST $2.74
- Analyst Decision
- TXMD
- AMST
- Analyst Count
- TXMD 0
- AMST 0
- Target Price
- TXMD N/A
- AMST N/A
- AVG Volume (30 Days)
- TXMD 17.2K
- AMST 14.0K
- Earning Date
- TXMD 08-12-2025
- AMST 09-29-2025
- Dividend Yield
- TXMD N/A
- AMST N/A
- EPS Growth
- TXMD N/A
- AMST N/A
- EPS
- TXMD N/A
- AMST N/A
- Revenue
- TXMD $2,559,000.00
- AMST $82,544.00
- Revenue This Year
- TXMD $427.09
- AMST N/A
- Revenue Next Year
- TXMD N/A
- AMST N/A
- P/E Ratio
- TXMD N/A
- AMST N/A
- Revenue Growth
- TXMD 156.93
- AMST N/A
- 52 Week Low
- TXMD $0.70
- AMST $2.00
- 52 Week High
- TXMD $2.44
- AMST $6.27
- Technical
- Relative Strength Index (RSI)
- TXMD 42.48
- AMST 47.08
- Support Level
- TXMD $1.05
- AMST $2.63
- Resistance Level
- TXMD $1.12
- AMST $2.83
- Average True Range (ATR)
- TXMD 0.04
- AMST 0.13
- MACD
- TXMD -0.00
- AMST 0.01
- Stochastic Oscillator
- TXMD 15.46
- AMST 53.85
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.
About AMST Amesite Inc.
Amesite Inc is an artificial intelligence-driven platform and course designer that rapidly provides customized, high-performance and scalable online products for schools and businesses. The company helps educational institutions and businesses improve learning as their technology partner, delivering a disruptive technology driven by AI and offers a constellation of services that help partners implement new programs, and improve existing ones. Its customers are Enterprises, universities, and K-12 schools.